You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 1, January 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  CASE REPORTS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Corneal Toxicity With an Antibiotic/Steroid—Soaked Collagen Shield

Stephen C. Pflugfelder, MD; J. Franklin Murchison, MD
Miami, Fla

Arch Ophthalmol. 1992;110(1):20.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In response to the Clinical Alert1 issued by the American Academy of Ophthalmology in November 1990 regarding corneal complications following the use of antibiotic/steroid—soaked collagen shields, we report a complication following the use of a antibiotic/steroid—soaked collagen shield used after surgery to decrease inflammation and prevent infection.

Report of a Case.

—An 84-year-old white woman underwent an uncomplicated extracapsular cataract extraction with insertion of a posterior chamber intraocular lens in her right eye in September 1990. At the conclusion of the procedure, a 12-hour collagen shield (Bausch & Lomb, Clearwater, Fla) soaked in tobramycin sulfate (40 mg/mL), vancomycin hydrochloride (50 mg/mL), and dexamethasone sodium phosphate (4 mg/mL) was placed on the eye. On the first postoperative day, severe diffuse epithelial and stromal corneal edema was observed, and the intraocular pressure was 10 mm Hg. The patient was treated with 1% topical prednisolone acetate 12 times a day and . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.